BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38480076)

  • 1. Evaluating Efficiency and Adherence in Asian Lung Cancer Screening: Comparing Self-paid and Clinical Study Approaches in Taiwan.
    Wu YJ; Tang EK; Wu FZ
    Acad Radiol; 2024 May; 31(5):2109-2117. PubMed ID: 38480076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.
    Barbosa EJM; Yang R; Hershman M
    AJR Am J Roentgenol; 2021 Apr; 216(4):919-926. PubMed ID: 32755178
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-dose CT screening among never-smokers with or without a family history of lung cancer in Taiwan: a prospective cohort study.
    Chang GC; Chiu CH; Yu CJ; Chang YC; Chang YH; Hsu KH; Wu YC; Chen CY; Hsu HH; Wu MT; Yang CT; Chong IW; Lin YC; Hsia TC; Lin MC; Su WC; Lin CB; Lee KY; Wei YF; Lan GY; Chan WP; Wang KL; Wu MH; Tsai HH; Chian CF; Lai RS; Shih JY; Wang CL; Hsu JS; Chen KC; Chen CK; Hsia JY; Peng CK; Tang EK; Hsu CL; Chou TY; Shen WC; Tsai YH; Tsai CM; Chen YM; Lee YC; Chen HY; Yu SL; Chen CJ; Wan YL; Hsiung CA; Yang PC;
    Lancet Respir Med; 2024 Feb; 12(2):141-152. PubMed ID: 38042167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified Lung-RADS Improves Performance of Screening LDCT in a Population with High Prevalence of Non-smoking-related Lung Cancer.
    Hsu HT; Tang EK; Wu MT; Wu CC; Liang CH; Chen CS; Mar GY; Lai RS; Wang JC; Wu CL; Huang YL; Wu FZ
    Acad Radiol; 2018 Oct; 25(10):1240-1251. PubMed ID: 29530488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung cancer probability and clinical outcomes of baseline and new subsolid nodules detected on low-dose CT screening.
    Kim YW; Kwon BS; Lim SY; Lee YJ; Park JS; Cho YJ; Yoon HI; Lee KW; Lee JH; Chung JH; Ji E; Lee CT
    Thorax; 2021 Oct; 76(10):980-988. PubMed ID: 33859050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient Adherence in an Academic Medical Center's Low-dose Computed Tomography Screening Program.
    Mortman KD; Devlin J; Giang B; Mortman R; Sparks AD; Napolitano MA
    Am J Clin Oncol; 2021 Jun; 44(6):264-268. PubMed ID: 33795600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer Risk in Subsolid Nodules in the National Lung Screening Trial.
    Hammer MM; Palazzo LL; Kong CY; Hunsaker AR
    Radiology; 2019 Nov; 293(2):441-448. PubMed ID: 31526256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Selection Criteria for Low-Dose Lung Screening CT Among Asian Ethnic Groups in Taiwan: From Mass Screening to Specific Risk-Based Screening for Non-Smoker Lung Cancer.
    Wu FZ; Huang YL; Wu CC; Tang EK; Chen CS; Mar GY; Yen Y; Wu MT
    Clin Lung Cancer; 2016 Sep; 17(5):e45-e56. PubMed ID: 27133540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung cancer screening with low-dose computed tomography: Experiences from a tertiary hospital in Taiwan.
    Chen CY; Chen CH; Shen TC; Cheng WC; Hsu CN; Liao CH; Chen CY; Hsia TC; Liao WC; Tu CY; Shih CM; Hsu WH
    J Formos Med Assoc; 2016 Mar; 115(3):163-70. PubMed ID: 26714425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying CT texture analysis to determine the prognostic value of subsolid nodules detected during low-dose CT screening.
    Sun Q; Huang Y; Wang J; Zhao S; Zhang L; Tang W; Wu N
    Clin Radiol; 2019 Jan; 74(1):59-66. PubMed ID: 30501892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to annual lung cancer screening with low-dose CT scan in a diverse population.
    Erkmen CP; Dako F; Moore R; Dass C; Weiner MG; Kaiser LR; Ma GX
    Cancer Causes Control; 2021 Mar; 32(3):291-298. PubMed ID: 33394208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns and Factors Associated With Adherence to Lung Cancer Screening in Diverse Practice Settings.
    Sakoda LC; Rivera MP; Zhang J; Perera P; Laurent CA; Durham D; Huamani Velasquez R; Lane L; Schwartz A; Quesenberry CP; Minowada G; Henderson LM
    JAMA Netw Open; 2021 Apr; 4(4):e218559. PubMed ID: 33929519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receipt of Recommended Follow-up Care After a Positive Lung Cancer Screening Examination.
    Rivera MP; Durham DD; Long JM; Perera P; Lane L; Lamb D; Metwally E; Henderson LM
    JAMA Netw Open; 2022 Nov; 5(11):e2240403. PubMed ID: 36326760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness of Treatment Thresholds for Subsolid Pulmonary Nodules in CT Lung Cancer Screening.
    Hammer MM; Eckel AL; Palazzo LL; Kong CY
    Radiology; 2021 Sep; 300(3):586-593. PubMed ID: 34128723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcomes of Resected Pure Ground-Glass, Heterogeneous Ground-Glass, and Part-Solid Pulmonary Nodules.
    Sun JD; Sugarbaker E; Byrne SC; Gagné A; Leo R; Swanson SJ; Hammer MM
    AJR Am J Roentgenol; 2024 May; 222(5):e2330504. PubMed ID: 38323785
    [No Abstract]   [Full Text] [Related]  

  • 16. Black patients referred to a lung cancer screening program experience lower rates of screening and longer time to follow-up.
    Lake M; Shusted CS; Juon HS; McIntire RK; Zeigler-Johnson C; Evans NR; Kane GC; Barta JA
    BMC Cancer; 2020 Jun; 20(1):561. PubMed ID: 32546140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting patient adherence to lung cancer screening: A multisite analysis.
    Stowell JT; Narayan AK; Wang GX; Fintelmann FJ; Flores EJ; Sharma A; Petranovic M; Shepard JO; Little BP
    J Med Screen; 2021 Sep; 28(3):357-364. PubMed ID: 32847462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Lung Cancer Risk Among Persons Undergoing Screening or Guideline-Concordant Monitoring of Lung Nodules in the Mississippi Delta.
    Osarogiagbon RU; Liao W; Faris NR; Fehnel C; Goss J; Shepherd CJ; Qureshi T; Matthews AT; Smeltzer MP; Pinsky PF
    JAMA Netw Open; 2023 Feb; 6(2):e230787. PubMed ID: 36848089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors Associated With Nonadherence to Lung Cancer Screening Across Multiple Screening Time Points.
    Lin Y; Liang LJ; Ding R; Prosper AE; Aberle DR; Hsu W
    JAMA Netw Open; 2023 May; 6(5):e2315250. PubMed ID: 37227725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.
    Field JK; Duffy SW; Baldwin DR; Brain KE; Devaraj A; Eisen T; Green BA; Holemans JA; Kavanagh T; Kerr KM; Ledson M; Lifford KJ; McRonald FE; Nair A; Page RD; Parmar MK; Rintoul RC; Screaton N; Wald NJ; Weller D; Whynes DK; Williamson PR; Yadegarfar G; Hansell DM
    Health Technol Assess; 2016 May; 20(40):1-146. PubMed ID: 27224642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.